BNGO · NASDAQ
Bionano Genomics (BNGO) Stock Price & Fundamentals
Bionano Genomics (BNGO) closed at $718.97 on Oct 9, 2026, up 1.73% from the previous close of $706.77.
Share price, past year
1Y +37.71%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $718.97 |
| Sep 30, 2026 | $686.00 |
| Aug 31, 2026 | $655.39 |
| Jul 31, 2026 | $656.65 |
| Jun 30, 2026 | $632.53 |
| May 29, 2026 | $618.47 |
| Apr 30, 2026 | $602.64 |
| Mar 31, 2026 | $588.13 |
| Feb 27, 2026 | $588.22 |
| Jan 30, 2026 | $573.49 |
| Dec 31, 2025 | $587.26 |
| Nov 28, 2025 | $570.78 |
| Oct 31, 2025 | $550.61 |
Key statistics
- Market cap
- $8.47B
- P/E (TTM)
- —
- EPS (TTM)
- −$3.11
- Revenue (TTM)
- $30.18M
- Net income (TTM)
- −$32.16M
- Shares outstanding
- 11.8M
- Dividend yield
- —
- 52-week range
- $519.28 – $718.97
Bionano Genomics's market cap is $8.47B, based on a share price of $718.97 and 11.8M shares outstanding as of Jun 30, 2026.
Financials
Bionano Genomics reported revenue of $28.51M for fiscal 2025, down 7.37% from fiscal 2024.
Bionano Genomics reported a net loss of $26.40M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $28.51M | −7.4% | −$26.40M | −92.6% | −$4.85 | — |
| FY2024ended Dec 31, 2024 | $30.78M | −14.8% | −$112.02M | −364.0% | −$88.13 | — |
| FY2023ended Dec 31, 2023 | $36.12M | +29.9% | −$232.49M | −643.7% | −$408.60 | — |
| FY2022ended Dec 31, 2022 | $27.80M | +54.6% | −$132.60M | −476.9% | −$16,521.17 | — |
| FY2021ended Dec 31, 2021 | $17.98M | +111.5% | −$72.44M | −402.8% | −$9,378.83 | — |
| FY2020ended Dec 31, 2020 | $8.50M | −16.1% | −$41.11M | −483.4% | −$14,068.25 | −$38.31M |
| FY2019ended Dec 31, 2019 | $10.13M | −15.6% | −$29.82M | −294.3% | −$71,784.14 | −$29.59M |
| FY2018ended Dec 31, 2018 | $12.00M | +26.3% | −$18.50M | −154.1% | −$94,149.05 | −$20.28M |
| FY2017ended Dec 31, 2017 | $9.51M | — | −$23.37M | −245.8% | −$312,026.55 | −$21.84M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $8.17M | −$7.42M | −$0.64 |
| Q1 FY2026ended Mar 31, 2026 | $6.69M | −$8.30M | −$0.76 |
| Q4 FY2025ended Dec 31, 2025 | $7.95M | −$7.93M | −$0.12 |
| Q3 FY2025ended Sep 30, 2025 | $7.37M | −$8.50M | −$1.59 |
| Q2 FY2025ended Jun 30, 2025 | $6.73M | −$6.86M | −$1.99 |
| Q1 FY2025ended Mar 31, 2025 | $6.46M | −$3.10M | −$1.15 |
| Q4 FY2024ended Dec 31, 2024 | $8.16M | −$20.13M | −$7.05 |
| Q3 FY2024ended Sep 30, 2024 | $6.07M | −$44.25M | −$30.92 |
Company profile
- Name
- Bionano Genomics, Inc.
- Ticker
- BNGO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Laboratory Analytical Instruments
- Headquarters
- 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001411690
Recent SEC filings
- Sep 14, 2026
- Aug 10, 2026
- Aug 10, 2026
- Jun 24, 2026
- Jun 5, 2026
- May 28, 2026
- May 14, 2026
- May 13, 2026
Frequently asked questions
What is Bionano Genomics's stock price?
Bionano Genomics (BNGO) closed at $718.97 on Oct 9, 2026, up 1.73% from the previous close of $706.77.
What is Bionano Genomics's market cap?
Bionano Genomics's market cap is $8.47B, based on a share price of $718.97 and 11.8M shares outstanding as of Jun 30, 2026.
How much revenue does Bionano Genomics make?
Bionano Genomics reported revenue of $28.51M for fiscal 2025, down 7.37% from fiscal 2024.
Does Bionano Genomics pay a dividend?
Bionano Genomics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Bionano Genomics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures